Endogenous S -nitrosothiols protect against myocardial injury
- 14 April 2009
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 106 (15), 6297-6302
- https://doi.org/10.1073/pnas.0901043106
Abstract
Despite substantial evidence that nitric oxide (NO) and/or endogenous S-nitrosothiols (SNOs) exert protective effects in a variety of cardiovascular diseases, the molecular details are largely unknown. Here we show that following left coronary artery ligation, mice with a targeted deletion of the S-nitrosoglutathione reductase gene (GSNOR(-/-)) have reduced myocardial infarct size, preserved ventricular systolic and diastolic function, and maintained tissue oxygenation. These profound physiological effects are associated with increases in myocardial capillary density and S-nitrosylation of the transcription factor hypoxia inducible factor-1alpha (HIF-1alpha) under normoxic conditions. We further show that S-nitrosylated HIF-1alpha binds to the vascular endothelial growth factor (VEGF) gene, thus identifying a role for GSNO in angiogenesis and myocardial protection. These results suggest innovative approaches to modulate angiogenesis and preserve cardiac function.This publication has 32 references indexed in Scilit:
- S-Nitrosylation of β-Arrestin Regulates β-Adrenergic Receptor TraffickingMolecular Cell, 2008
- Dynamics of the Hypoxia-inducible Factor-1-Vascular Endothelial Growth Factor Promoter ComplexOnline Journal of Public Health Informatics, 2007
- S -nitrosohemoglobin deficiency: A mechanism for loss of physiological activity in banked bloodProceedings of the National Academy of Sciences of the United States of America, 2007
- S-Nitrosothiols signal hypoxia-mimetic vascular pathologyJCI Insight, 2007
- Akt-Mediated Activation of HIF-1 in Pulmonary Vascular Endothelial Cells by S-NitrosoglutathioneAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Regulation of HIF-1α Stability through S-NitrosylationMolecular Cell, 2007
- Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapyProceedings of the National Academy of Sciences of the United States of America, 2006
- Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefactionJCI Insight, 2006
- S-Nitrosohemoglobin: an allosteric mediator of NO group function in mammalian vasculatureFree Radical Biology & Medicine, 2004
- HIF‐1α protein as a target for S‐nitrosationFEBS Letters, 2003